E
SRTA

Ergoteles’s Strata Critical Medical Inc SRTA Stock Holding History

Ergoteles’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,600
Closed -$175K – 1646
2022
Q1 		$175K Buy
+20,600
New +$145K 0.01% 1031

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's SRTA Position: Q2 2022 in Review

Ergoteles sold out of Strata Critical Medical Inc (SRTA) in Q2 2022, closing a stake of 20,600 shares — an estimated $175K sold.

Ergoteles first reported a position in SRTA in Q1 2022 and held it in 1 quarter. The position peaked at $175K in Q1 2022. 96 funds tracked by Wall St. Rank hold SRTA as of Q2 2022.

  • Ergoteles reported no remaining Strata Critical Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Ergoteles sold 20,600 Strata Critical Medical Inc shares in Q2 2022, an estimated $175K.
  • Ergoteles first reported a position in Strata Critical Medical Inc in Q1 2022 and held it in 1 quarter.
  • Ergoteles's Strata Critical Medical Inc position peaked at $175K in Q1 2022.
  • 96 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2022.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.